Cullivan Julie A 4

What Happened
Julie A. Cullivan, a director of Heartflow, sold 8,000 shares on February 5, 2026 at $27.32 per share, generating proceeds of $218,560. The transaction was reported on a Form 4 filed February 6, 2026. This was a sale (S), which is often routine and does not by itself signal a change in insider sentiment.

Key Details

• Transaction date: 2026-02-05
• Transaction type and size: Open-market sale (S) of 8,000 shares @ $27.32
• Gross proceeds: $218,560
• Shares owned after transaction: Not disclosed in the information provided (see the full Form 4 for holdings)
• Footnote: Sale was executed under a Rule 10b5-1 trading plan adopted by Ms. Cullivan on September 12, 2025
• Filing timeliness: Form 4 filed 2026-02-06 (timely relative to the reported trade date)

Context
A 10b5-1 plan lets insiders sell pre-specified amounts at set times, which can make sales more routine and less informative about current views. For retail investors, individual insider sales are one data point—consider overall insider activity and company fundamentals before drawing conclusions.